Active ingredient: Quetiapine (as fumarate) 50 mg
Dosage form: Prolonged-release tablets (LP)
Pack size: 30 tablets
Manufacturer: Mylan Pharma (France)
Route: Oral use
Quetiapine is an atypical antipsychotic that acts on serotonin and dopamine receptors. The prolonged-release (LP) form releases the substance gradually, allowing once-daily dosing and smoother plasma levels with fewer peaks — this improves tolerability, especially at the start of therapy.
Quetiapine is one of the most prescribed antipsychotics worldwide, used across psychiatric practice far beyond schizophrenia, including bipolar disorder and augmentation in depression. The product is manufactured in France by Mylan Pharma and is a prescription-only medicine.
The prolonged-release tablet is taken once daily, in the evening, without crushing or chewing. Initial dose and titration are determined by the physician; the tablet may be taken with or without food, but consistent intake is recommended.
Dose changes and discontinuation are managed only by the treating physician.
The tablet releases quetiapine gradually over 24 hours, allowing once-daily evening dosing and smoother plasma levels than immediate-release forms.
Once daily in the evening, as prescribed by a physician, without crushing the tablet.
Sedative effect may appear within days; the full antipsychotic or mood-stabilizing effect develops over 2-4 weeks.
Yes, it is a prescription-only medicine requiring medical supervision.
No. Prolonged-release tablets must be swallowed whole.
Delivery only to EU countries and the United Kingdom!
Ask a question or inquire about delivery to your country
